Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Nanopore sequencing of clonal IGH rearrangements in cell-free DNA as a biomarker for acute lymphoblastic leukemia

Frontiers in Oncology(2022)10.3389/fonc.2022.958673Source: DataRank Database

Nanopore sequencing of clonal IGH rearrangements in cell-free DNA as a biomarker for acute lymphoblastic leukemia is a research paper published in Frontiers in Oncology (2022). On theSindex it has a DataRank of 0. It has been cited 21 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access21 citations

Download PDF

Cite:

Linked data & code

bioproject uniprot

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)OA: goldTopics (11)IDs (PubMed, PMC)Annotations (2)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (11)

Yelena Chernyavskaya,Meghan G. Haney ORCID,L. Henry Moore ORCID,Isabel A. Snyder,Anna H. Cox

Live enrichment

PubMed:36591474 PMC:PMC9795051

NCI NIH HHS

Grant: DP2 CA228043

NCI NIH HHS

Grant: R37 CA227656

National Institutes of Health

Grant: 3T32CA165990-02S2

Interdisciplinary Research Training in Cancer Biology

National Institutes of Health

Grant: 5R37CA227656-04

The phosphatase PRL3 as a MYC target and pro-survival oncogene in Acute Lymphoblastic Leukemia

National Institutes of Health

Grant: 1DP2CA228043-01

Harnessing Single Cell Technology to Define Self-Renewal in Normal and Malignant Stem Cells

National Institutes of Health

goldLicense: cc-by

publisherhttps://www.frontiersin.org/articles/10.3389/fonc.2022.958673/pdf

publisherhttps://www.frontiersin.org/articles/10.3389/fonc.2022.958673/full

repositoryhttps://doaj.org/article/88b631c58e034e68bd52d1b457e89b2d

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9795051

Unpaywallhttps://doi.org/10.3389/fonc.2022.958673

Fields of Study

03 medical and health sciences0302 clinical medicine

Keywords

ClonalityRelapseVdj RearrangementMinimal Residual Disease (Mrd)B-cell Acute Lymphoblastic Leukemia (B-all)Central Nervous System (Cns) DiseaseOncologyNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282

Sustainable Development Goals

SDG 3: 3. Good health

Nanopore sequencing of clonal IGH rearrangements in cell-free DNA as a biomarker for acute lymphoblastic leukemia

FAIR Checklist

Authors (11)

Funding (6 grants)

Open Access

Topics

Annotations (Europe PMC)